Patent · US Active

Antibodies recognizing tau

US11958896B2 · kind B2 · utility

0Cited by
67References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 2, 2018
Grant dateApr 16, 2024
Priority date
Expiry dateDec 23, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.